Cardiac structure and function parameters of elite athletes, recreationally active controls and HCM patients
| Athletes (n=17) | Controls (n=9) | HCM (n=18) | p Value | |
|---|---|---|---|---|
| Cardiac | ||||
| LVIDd (mm) | 52±6† | 52±5† | 46±5 | 0.003 |
| LVEDV (ml) | 132±31† | 126±25† | 96±26 | 0.002 |
| PWT (mm) | 12±1 | 10±2 | 12±4 | 0.113 |
| ST (mm) | 13±2 | 11±1† | 15±4 | 0.002 |
| LVM (g) | 263±36 | 208±33 | 257±95 | 0.112 |
| LVEDV/LVM | 0.50±0.09 | 0.60±0.10† | 0.41±0.16 | 0.002 |
| % EF | 62±7 | 58±8 | 68±12 | 0.056 |
| SV (ml) | 83±27 | 71±18 | 71±17 | 0.328 |
| E/A | 1.84±0.50† | 2.02±0.56† | 1.39±0.45 | 0.011 |
Data are mean±SD.
E/A, ratio of peak early to atrial left ventricular filling velocities; EF, ejection fraction; HCM, hypertrophic cardiomyopathy; LVEDV, left ventricular end-diastolic; LVIDd; LVM, left ventricular mass; PWT, posterior wall thickness; ST, septal wall thickness; SV, stroke volume.
Significantly different when post hoc tests are applied to *compared to controls †compared to HCM, p<0.05.